Cargando…

More advanced Alzheimer's disease may be associated with a decrease in cerebrospinal fluid pressure

In a recent article, elevated cerebrospinal fluid pressure (CSFP) consistent with very early normal pressure hydrocephalus (NPH), was found in a small subset of Alzheimer's disease (AD) patients (possible AD-NPH hybrids) enrolled in a clinical trial for chronic low-flow cerebrospinal fluid drai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wostyn, Peter, Audenaert, Kurt, De Deyn, Peter Paul
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780980/ https://www.ncbi.nlm.nih.gov/pubmed/19917128 http://dx.doi.org/10.1186/1743-8454-6-14

Ejemplares similares

Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer’s Disease Therapy
por: Wostyn, Peter, et al.
Publicado: (2011)

Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
por: Wostyn, Peter, et al.
Publicado: (2011)

A new glaucoma hypothesis: a role of glymphatic system dysfunction
por: Wostyn, Peter, et al.
Publicado: (2015)

A New Look at Glaucoma
por: Wostyn, Peter, et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

The Glymphatic Hypothesis of Glaucoma: A Unifying Concept Incorporating Vascular, Biomechanical, and Biochemical Aspects of the Disease
por: Wostyn, Peter, et al.
Publicado: (2017)

Dilated Virchow-Robin spaces in primary open-angle glaucoma: a biomarker of glymphatic waste clearance dysfunction?
por: Wostyn, Peter, et al.
Publicado: (2016)

Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease
por: Niemantsverdriet, Ellis, et al.
Publicado: (2016)

Are Generalized Reduced Cerebrospinal Fluid Dynamics and Optic Nerve Sheath Compartmentation Sequential Steps in the Pathogenesis of Normal-Tension Glaucoma? [Letter]
por: Wostyn, Peter
Publicado: (2021)

Cerebrospinal Fluid Pressure Decreases with Older Age
por: Fleischman, David, et al.
Publicado: (2012)

Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
por: Silverberg, Gerald, et al.
Publicado: (2006)

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis
por: Janssens, Jana, et al.
Publicado: (2018)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

Could Young Cerebrospinal Fluid Combat Glaucoma? Comment on Lee et al. Association between Optic Nerve Sheath Diameter and Lamina Cribrosa Morphology in Normal-Tension Glaucoma. J. Clin. Med. 2023, 12, 360
por: Wostyn, Peter
Publicado: (2023)

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2019)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Drug transport in brain via the cerebrospinal fluid
por: Pardridge, William M
Publicado: (2011)

A new look at cerebrospinal fluid movement
por: Orešković, Darko, et al.
Publicado: (2014)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
por: Perea, Juan R., et al.
Publicado: (2018)

Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2023)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)

Noninvasive surrogates of intracranial pressure: another piece added with magnetic resonance imaging of the cerebrospinal fluid thickness surrounding the optic nerve
por: Geeraerts, Thomas
Publicado: (2013)

Protein fibril length in cerebrospinal fluid is increased in Alzheimer’s disease
por: Nirmalraj, Peter Niraj, et al.
Publicado: (2023)

Cerebrospinal Fluid Pressure and Glaucoma
por: Jonas, Jost B., et al.
Publicado: (2013)

The choroid plexus-cerebrospinal fluid interface in Alzheimer's disease: more than just a barrier
por: Balusu, Sriram, et al.
Publicado: (2016)

Comparison of cerebrospinal fluid space between probable normal pressure hydrocephalus and Alzheimer’s disease
por: Li, Hongliang, et al.
Publicado: (2023)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer’s disease
por: Sutphen, Courtney L., et al.
Publicado: (2018)

Concordance of Alzheimer’s Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus
por: Lukkarinen, Heikki, et al.
Publicado: (2023)

Report on a conference analyzing the role of cerebrospinal fluid prophylaxis for brain tumors
por: Glantz, Michael, et al.
Publicado: (2008)

Distinct volumetric features of cerebrospinal fluid distribution in idiopathic normal-pressure hydrocephalus and Alzheimer’s disease
por: Han, Jaehwan, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
por: McGrowder, Donovan A., et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus
por: Leinonen, Ville, et al.
Publicado: (2011)

More is Needed before Alzheimer’s Disease can be Conquered
por: YU, Xin
Publicado: (2017)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease
por: Barichello, Tatiana, et al.
Publicado: (2019)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ufcacaq4o0ukijo62jvn026eo